new life research foundation

Navigation Menu

Search code, repositories, users, issues, pull requests..., provide feedback.

We read every piece of feedback, and take your input very seriously.

Saved searches

Use saved searches to filter your results more quickly.

To see all available qualifiers, see our documentation .

• Repositories

New Life Research Foundation (NELIREF) newliferesearchfoundation

• New Life Research Foundation (NELIREF)

Block or report newliferesearchfoundation

Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users .

You must be logged in to block users.

Contact GitHub support about this user’s behavior. Learn more about reporting abuse .

Popular repositories

Course completed at Georgia Institute of Technology

Supporting exceptional postdoctoral researchers in all areas of basic life sciences discovery

Average number of completed submissions received by lsrf every october since the first call for proposals in 1982., our 9 officers, 20 advisory board members and 35 review committee members all volunteer their services. these groups include 6 nobel laureates and 36 nas members., number of postdocs funded since our first class of awardees was announced in 1983. this is only possible with generous financial support from sponsors., average number of postdocs funded annually. this number varies each year and is tied to our annual fundraising efforts. lsrf has no endowment or pool of funds., donald d. brown (1931-2023), don brown memorial fund.

Numbers, Facts and Trends Shaping Your World

Read our research on:

Full Topic List

Regions & Countries

Publications

• Our Methods
• Short Reads
• Tools & Resources

Read Our Research On:

Internet & Technology

6 facts about americans and tiktok.

62% of U.S. adults under 30 say they use TikTok, compared with 39% of those ages 30 to 49, 24% of those 50 to 64, and 10% of those 65 and older.

Many Americans think generative AI programs should credit the sources they rely on

Americans’ use of chatgpt is ticking up, but few trust its election information, whatsapp and facebook dominate the social media landscape in middle-income nations, sign up for our internet, science, and tech newsletter.

New findings, delivered monthly

Electric Vehicle Charging Infrastructure in the U.S.

64% of Americans live within 2 miles of a public electric vehicle charging station, and those who live closest to chargers view EVs more positively.

When Online Content Disappears

A quarter of all webpages that existed at one point between 2013 and 2023 are no longer accessible.

A quarter of U.S. teachers say AI tools do more harm than good in K-12 education

High school teachers are more likely than elementary and middle school teachers to hold negative views about AI tools in education.

Teens and Video Games Today

85% of U.S. teens say they play video games. They see both positive and negative sides, from making friends to harassment and sleep loss.

Americans’ Views of Technology Companies

Most Americans are wary of social media’s role in politics and its overall impact on the country, and these concerns are ticking up among Democrats. Still, Republicans stand out on several measures, with a majority believing major technology companies are biased toward liberals.

22% of Americans say they interact with artificial intelligence almost constantly or several times a day. 27% say they do this about once a day or several times a week.

About one-in-five U.S. adults have used ChatGPT to learn something new (17%) or for entertainment (17%).

Across eight countries surveyed in Latin America, Africa and South Asia, a median of 73% of adults say they use WhatsApp and 62% say they use Facebook.

5 facts about Americans and sports

About half of Americans (48%) say they took part in organized, competitive sports in high school or college.

REFINE YOUR SELECTION

Research teams, signature reports.

The State of Online Harassment

Roughly four-in-ten Americans have experienced online harassment, with half of this group citing politics as the reason they think they were targeted. Growing shares face more severe online abuse such as sexual harassment or stalking

Parenting Children in the Age of Screens

Two-thirds of parents in the U.S. say parenting is harder today than it was 20 years ago, with many citing technologies – like social media or smartphones – as a reason.

Dating and Relationships in the Digital Age

From distractions to jealousy, how Americans navigate cellphones and social media in their romantic relationships.

Americans and Privacy: Concerned, Confused and Feeling Lack of Control Over Their Personal Information

Majorities of U.S. adults believe their personal data is less secure now, that data collection poses more risks than benefits, and that it is not possible to go through daily life without being tracked.

Americans and ‘Cancel Culture’: Where Some See Calls for Accountability, Others See Censorship, Punishment

Social media fact sheet, digital knowledge quiz, video: how do americans define online harassment.

1615 L St. NW, Suite 800 Washington, DC 20036 USA (+1) 202-419-4300 | Main (+1) 202-857-8562 | Fax (+1) 202-419-4372 |  Media Inquiries

Research Topics

• Email Newsletters

ABOUT PEW RESEARCH CENTER  Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. It conducts public opinion polling, demographic research, media content analysis and other empirical social science research. Pew Research Center does not take policy positions. It is a subsidiary of  The Pew Charitable Trusts .

© 2024 Pew Research Center

Our WRF Postdoctoral Fellowship application is now open! >>

WRF awards more than $2 million in grants to support the development of plans for life-science initiatives in the state

Investigators at Fred Hutch Cancer Center, the Seattle Hub for Synthetic Biology, the University of Washington and Washington State University will use funding to develop plans for large-scale efforts that can significantly enhance the life-science innovation ecosystem in Washington state

Seattle, WA – May 30, 2024

Washington Research Foundation (WRF) has awarded nearly $2.2 million in new grant funding to researchers at four nonprofit institutions in Washington state. WRF funded 12 teams of investigators at Fred Hutch Cancer Center (Fred Hutch), the Seattle Hub for Synthetic Biology, the University of Washington (UW) and Washington State University (WSU) to develop detailed plans for projects and programs that could significantly advance the state’s life-science ecosystem and improve lives.

WRF concluded an eight-month strategic planning process last year and committed to increasing its support of big, emergent opportunities in the region over the next five years. The call for planning grants was one way to surface ideas for such opportunities. Another program that resulted from the strategic planning process was a call to support IND-enabling and clinical studies for novel therapeutics . Awards made through that program will be announced in the coming weeks.

Over the next 12 to 18 months, each team will use its planning grant to develop a proposal for a large-scale initiative—potentially on a similar scale to the Invent at Seattle Children’s Postdoctoral Scholars Program that WRF has supported since its launch in 2022—for submission to WRF and/or other funding agencies. In its RFP for this award, WRF encouraged investigators to consider elements including potential collaborations between institutions, building diverse, equitable and inclusive innovation ecosystems, and exploring commercialization paths for new technologies to address unmet public needs in the region.

WRF awarded a total of $2,190,486 to support comprehensive planning for the following projects:

• Jennifer Adair, Ph.D. , will lead the development of a funding proposal for Bridging the Clinical Gap: Adding Value to the “Discovered Here in Washington” Therapeutic Ecosystem at Fred Hutch
• Joshua Hill, MD , will lead Immunotherapeutic Approaches to Prevent and Treat Infections in Immunocompromised Hosts: The ImmunoPTImize Network at Fred Hutch
• Andrew Hsieh, MD , will lead Towards an integrated research ecosystem on bladder cancer heterogeneity in the Pacific Northwest at Fred Hutch
• Jay Shendure, MD, Ph.D. , will lead SeaHub Programmable Cells & Genomes Network (PCGN) at the Seattle Hub for Synthetic Biology
• Jennifer Davis, Ph.D. , will lead Platforms of Human Aging and Disease in a Dish (PHADD) Technical Hub at UW
• Elizabeth Nance, Ph.D. , will lead A Pipeline for Novel Engineered Neurotherapeutics in Newborns at UW
• Shelly Sakiyama-Elbert, Ph.D. , will lead Washington Initiative for Neuroscience (WIN) at UW
• Kelly Stevens, Ph.D. , will lead Volumetric Imaging and Spatial Tissue Analysis (VISTA) at UW
• Jayanth Panyam, Ph.D. , will lead Institute for Drug Delivery at UW
• Kevin Murphy, Ph.D. , will lead Optimizing human health and nutrition from Soil to Society at WSU
• Jon Oatley, Ph.D. , will lead WA Consortium on Reproductive Health at WSU
• Ken Roberts, Ph.D. , will lead Planning a Center of Excellence for Translational Neuroscience (CETN) at WSU

Meher Antia, Ph.D., WRF’s director of grant programs, said that the planning grants are intended to give investigators the time and resources to fully map out ideas for ambitious and achievable high-impact projects that could significantly improve lives in Washington state and beyond.

“We were delighted to see the interest that was generated by our call for creative, collaborative ideas that would spur innovation in Washington,” Antia said. “The planning grants are just the beginning of a process that we hope will result in long-term impact in a broad variety of life science areas.”

Give Monthly

Give In Honor

National Foundation For Cancer Research

NFCR provides scientists in the labs the funding they need to make game-changing discoveries in cancer treatments, detection, prevention, and ultimately, a cure for all types of cancer.

Our Goal and Approach

• We are one of few charities willing to take risks and fund the most innovative ideas in cancer research.
• We understand the critical unmet needs of cancer patients and support the forefront of new cancer research ideas.

Together, we can make cancer history.

View our latest video to learn more about NFCR’s mission, focus and unique approach to cancer research. 

Help Make Cures Possible

Your gift today will accelerate cancer research to help improve prevention, detection, and treatment for all types of cancer.

How to Get Involved

Youth Fundraising Programs

Fundraise on Social Media

Find More Ways to Get Involved!

Testimonials.

“Cancer is a disease that can be cure…”

M.D., Ph.D. 1937 Nobel Laureate, NFCR Co-Founder

“As a metastatic breast cancer patient undergoing treatment, I intimately know that patients and research are in a marathon. The record speed in the development of the COVID-19 vaccine came from the groundwork of past research. Other diseases demand similar critical attention and research. We have supported NFCR since 1999. We appreciate that their national position promotes a thoughtful continuum where feedback loops from across the country to inform research, coordination, and collaboration. NFCR helps break down the silos that stifle research.”

Late supporter and Former Executive Director, The Alvin H. Baum Fund

“Donors are the linchpin. Not only do I thank you, the World will thank you.”

Scientific Advisor   Watch this video to learn more about how NFCR has supported many breakthroughs that are helping to identify and minimize the impact of metastasis on cancer patients.

Latest News

The National Foundation for Cancer Research offers the latest news and information in cancer research, treatment, prevention and education. We encourage you to sign-up to explore our newsletter articles, blog posts, survivor stories, local events and more.

Research Pioneer and Paradigm-Shifting Thought Leader for Breast Cancer Precision Medicine to Receive the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Highlighting NFCR Supported Research Scientists at the 2024 ASCO Annual Meeting

NFCR CEO Dr. Sujuan Ba Honored at AAPI Women’s Gala 2024

Cancer Intervention vs. Prevention: What Does it Mean?

NFCR’s Annual Giving Day: June 13th to the 14th

NFCR-Supported Dr. Rakesh K. Jain Named 2023 Cozzarelli Prize Finalist

NFCR Congratulates Dr. Steven A. Rosenberg on his Lifetime Achievement Award

25 NFCR Affiliates Involved in 2024 AACR Annual Meeting

Reflecting on Women’s History Month & NFCR’s Commitment

Join our mailing list.

National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization. Tax ID #: 04-2531031

• Privacy Policy
• Other Policies
• Terms of Use
• Financials & 990
• Frequently Asked Questions

5515 Security Lane, Suite 1105 Rockville, MD 20852

1-800-321-CURE (2873)

[email protected]

Donor Portal

© Copyright 2024 National Foundation for Cancer Research. All Rights Reserved.

Your ticket for the: Research for a Cure

Research for a cure.

Find Info For

• Current Students
• Prospective Students
• Research and Partnerships
• Entrepreneurship and Commercialization

Quick Links

• Health and Life Sciences
• Info Security and AI
• Transformative Education
• Purdue Today
• Purdue Global
• Purdue in the News

May 28, 2024

Purdue joins Lilly at LEAP in pharmaceutical training facility

Purdue and Lilly will continue to build upon their collaborative Lilly Scholars program, which helps Boilermaker students earn pharmaceutical manufacturing scholarships and unique learning opportunities at the company. (Purdue for Life Foundation photo/Brayden Williams)

Lilly announced on May 24 its additional investment to the LEAP District, including a new training facility in partnership with Purdue. LEAP is the midpoint along the Hard-Tech Corridor between Purdue's campuses in Indianapolis and West Lafayette.

INDIANAPOLIS — Purdue University is continuing its collaboration with Eli Lilly and Company as the Indianapolis-based pharmaceutical company’s official education partner at Indiana’s LEAP Research and Innovation District. Lilly announced plans to invest another $5.3 billion in its brand-new Boone County manufacturing complex on Friday (May 24), bringing the total investment to $9 billion. LEAP is a key part of the Hard-Tech Corridor from Purdue University’s flagship campus in West Lafayette to the heart of downtown Indianapolis .

Purdue and Lilly will continue to build upon their collaborative scholarship and training program, the Lilly Scholars program , which helps Boilermaker students earn pharmaceutical manufacturing scholarships and unique learning opportunities with Lilly, one of the world’s most innovative pharmaceutical companies. The inaugural Purdue class of Lilly Scholars just completed the 2023-24 academic year. The dynamic program offers 50-100 talented students full tuition with a guaranteed internship at Lilly and a promise of coordinated interaction with company leaders. Participating students will then be provided opportunities to compete for a role at the company following graduation.

As Lilly and Purdue work together on new curricula, experiential learning, and certificate and degree programs in pharmaceutical manufacturing, they will help continue to grow pharmaceutical manufacturing in Indiana and expand Purdue’s talent pipeline to the company with students supported by the scholarship program.

Lilly and Purdue have collaborated on multiple fronts over the years, but especially in 2024. The company’s world headquarters are less than a mile away from the new One Health Innovation District . That partnership between Purdue and Elanco, an animal health leader that was previously a subsidiary of Lilly before being divested, was announced on May 23. In January, Lilly Endowment Inc. approved two grants totaling $100 million to Purdue Research Foundation to support two major Purdue University initiatives — the Mitchell E. Daniels, Jr. School of Business and Purdue Computes — both of which were identified last year by Purdue as top  strategic initiatives  for the university. Together those commitments represented the largest gift in the university’s history.

About Purdue University  

Purdue University is a public research institution demonstrating excellence at scale. Ranked among top 10 public universities and with two colleges in the top four in the United States, Purdue discovers and disseminates knowledge with a quality and at a scale second to none. More than 105,000 students study at Purdue across modalities and locations, including nearly 50,000 in person on the West Lafayette campus. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition 13 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its first comprehensive urban campus in Indianapolis, the new Mitchell E. Daniels, Jr. School of Business, and Purdue Computes — at https://www.purdue.edu/president/strategic-initiatives .  

Writer/Media contact:  Derek Schultz,  [email protected]

Research News

Communication.

• OneCampus Portal
• Brightspace
• BoilerConnect
• Faculty and Staff
• Human Resources
• Colleges and Schools

Info for Staff

• Purdue Moves
• Board of Trustees
• University Senate
• Center for Healthy Living
• Information Technology
• Ethics & Compliance
• Campus Disruptions

Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

© 2015-24 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by Office of Strategic Communications

Trouble with this page? Disability-related accessibility issue? Please contact News Service at [email protected] .

Expert Tips on How to Get Good Sleep with Parkinson's

Sleep recharges our brains and bodies, while boosting mental wellness. People living with Parkinson’s disease (PD) need even more time to reset and restore. Discover how Parkinson’s symptoms, medications or other health problems can impact your sleep, and what you can do to maximize slumber.

This article is based on  Trouble with Zzz's: Sleep Challenges with Parkinson's , a Parkinson’s Foundation  Expert Briefing  webinar presented Aleksandar Videnovic, MD, MSc, associate professor of neurology at Harvard Medical School and director for the Massachusetts General Hospital Division of Sleep Medicine and Program on Sleep, Circadian Biology and Neurodegeneration.

Aging, PD and Trouble with Sleep

As people age, it may be harder to fall asleep and waking up at night can be more frequent. Parkinson’s can further disrupt restorative sleep . As many as 80-90% of people with Parkinson’s can experience a sleep problem during the course of the disease.

Parkinson’s-related brain changes upset the circadian system, sometimes called the body’s internal clock. PD also impacts sleep drive — the growing sensation as day turns to night of the need to sleep. Other elements of PD that can disrupt slumber include:

• Parkinson's symptoms , such as tremor or PD-related pain , may emerge overnight as medications wear off. Other symptoms include akinesia (difficulty moving or inability to move), rigidity, dyskinesia (erratic, involuntary movement) and more.
• Medications used to treat PD can interfere with sleep. Others can make it harder to stay alert during the day.
• Depression and anxiety are extremely common PD symptoms. These and other symptoms, such as hallucinations , can keep a person awake at night.
• Changes to the autonomic system , the body’s network for regulating jobs like breathing and blood pressure, impact sleep. Nocturia — excessive nighttime urination — can be common in PD.

Sleep disorders can be exhausting for a person with Parkinson’s, as well as their bed partner. These can include:

• Obstructive sleep apnea and other sleep-disordered breathing can obstruct the airway repeatedly during sleep, resulting in coughing, choking and frequent waking. People with sleep-disordered breathing experience microarousals, waking up to 60 times hourly, without recognizing it. Sleep apnea affects up to 10% of the population, impacting people without Parkinson’s and those with PD with the same frequency.
• Excessive daytime sleepiness (EDS) may make it difficult to stay awake during daylight hours or cause sudden daytime sleep. PD brain changes and symptoms, medication regimens, co-existent sleep disorders and age-related physical changes can all cause EDS. Up to 16% or more of people with PD may experience poor daytime alertness. Some may be unaware of how EDS affects them. A trusted companion can offer honest input. Sometimes, sleep attacks can come on without any warning, significantly impacting a person’s ability to drive safely .
• Restless legs syndrome (RLS), an uncomfortable feeling in the legs or feet and irresistible need to move, can impact some people even prior to a PD diagnosis. However, not everyone with Parkinson’s experiences RLS, nor will most people who experience RLS go on to develop PD.
• Rapid eye movement (REM) sleep behavior disorder (RBD): People dream and experience muscle relaxation during REM stage of sleep. RBD can affect up to half of people with Parkinson’s, impacting muscle relaxation and causing people to act out their dreams — talking, yelling or moving about.

Like restless legs syndrome, RBD can begin long before a Parkinson’s diagnosis. Although not everyone who lives with RBD will develop Parkinson’s, their risk of developing PD or Dementia with Lewy Bodies — diagnosed when cognitive decline happens before or alongside motor symptoms  —  is significantly higher. This is meaningful for Parkinson’s research.

As potential therapies evolve to slow PD progression, there may be a window of opportunity for preventative intervention in people who experience REM sleep behavior disorder but have yet to develop a neurodegenerative disease.

Management Strategies for Fragmented Sleep

Talk to your healthcare provider about sleep issues, fatigue or daytime sleepiness. Your doctor may ask questions about your sleep history. A careful review of each or your medications will help your doctor determine whether a simple adjustment or addition might improve slumber:

• Long-acting levodopa or additional levodopa is sometimes prescribed for bedtime use.
• Catechol-O-methyl transferase (COMT) is an enzyme in the body. It can impact the effectiveness of levodopa. COMT inhibitors prolong the benefits of levodopa. These are primarily used for wearing off (changes in the ability to move between doses of levodopa) but are sometimes also prescribed with levodopa for use at night.
• People taking diuretics might be directed to use them earlier in the day. Likewise, limiting the use of PD medications selegiline and amantadine later in the day might improve insomnia.
• Anticholinergic medications are sometimes used for nocturia, however, cognitive slowing can be a side effect. These can also cause confusion and hallucinations and are not recommended in older people.
• Caffeine and some stimulant medications can promote alertness during the day.

Mental wellness: Talk to your doctor about symptoms of depression or other emotional challenges. Parkinson’s impacts areas of the brain that regulate mood, sleep, energy and more. Caring for mental health also benefits sleep.

Sleep disorders : If your doctor suspects a sleep disorder such as obstructed breathing, restless legs or RBD, you might be referred for a sleep study in a sleep clinic.

• Sleep apnea treatment may require a dental appliance or a continuous positive airway pressure (CPAP) machine that is worn when sleeping or napping.
• Dopamine agonists — medications that rouse areas of the brain motivated by dopamine — benzodiazepines, opioids and a class of medications known as calcium channel alpha-2 delta ligands, such a gabapentin, are sometimes used for restless legs syndrome. Dopamine-blocking, anticholinergic and antihistamine medications should be avoided for RLS.
• Your doctor may recommend melatonin or the medication clonazepam for RBD. While antidepressants may help with some aspects of insomnia, some can unmask or worsen RBD.

Tips to Improve Shut-eye

A healthy sleep routine — sometimes called sleep hygiene — is another key component to a good night’s rest. Try these small changes that can make a big difference:

• Exercise regularly (aim for early in the day) to improve sleep quality and overall function.
• Limit naps: a short snooze earlier in the day, of 30 minutes or less, is less likely to interfere with nighttime sleep. 
• Avoid stimulants, such as caffeine, later in the day.
• Minimize your screen time before bed. Avoid screens entirely — including TV and mobile devices — in the bedroom.
• Go to sleep and rise at the same time, weekdays and weekends.
• Turn the lights out: light regulates the body’s clock, signaling that it is time to wake.
• Employ motion-detecting nightlights to safely guide you to the bathroom.
• Sleep in a wider bed that is lower to ground. This can minimize injuries and lessen the impact in case of an accidental fall.
• Consider a bedside rail to prevent falls; a bedside commode can also be helpful for people who have difficulty getting to the toilet at night.
• Use satin or silk sheets or pajamas to make it easier to turn in bed.

Adequate hydration can improve PD symptoms, boosting low blood pressure and easing constipation. However, drinking liquids too close to bedtime can cause frequent nighttime urination. Minimize beverages a few hours before bed.

Light hitting the eyes is one of the biggest environmental factors regulating the circadian system. The timing of meals, exercise, naps and rest also influences our body clock. In turn, this timer regulates our mood, behavior, immune response and more. Researchers are exploring ways to improving circadian system function in PD.

Light therapy shows great promise as a noninvasive, widely available, nonpharmacological treatment to ease non-movement symptoms of Parkinson’s, including fatigue, sleep issues and mood changes.

In a 2017 JAMA Neurology journal study, Videnovic et al. found that exposure to bright light (10,000 lux) or dim-red light (less than 300 lux) — twice daily in one-hour sessions over two weeks — improved daytime alertness and sleep quality.

Those findings were carried over into the recently completed ENLITE PD trial conducted at 25 sites across North America. The study analyzes the effect of daily light therapy on PD symptoms, including sleep. At the time of this Expert Briefing, the study’s authors were preparing to submit their findings for publication, with the aim of conducting a phase III clinical trial.

To learn more about Parkinson’s and sleep explore these resources:

• Parkinson’s Disease and Sleep
• Sleep Disorders
• Care Partner Deep Dive: Three Experts Discuss Sleep, Cognition and Mood in Parkinson's

Videnovic, A., Klerman, E. B., Wang, W., Marconi, A., Kuhta, T., & Zee, P. C. (2017). Timed light therapy for sleep and daytime sleepiness associated with parkinson disease.  JAMA Neurology ,  74 (4), 411. https://doi.org/10.1001/jamaneurol.2016.5192

Related Materials

Sleep: a mind guide to parkinson's disease, episode 121: parkinson’s disease and sleep, sleep problems in parkinson’s, related blog posts.

Sleep and Parkinson’s: Non-Motor Quality of Life

7 Tips for Better Sleep

New Study Examines Impulse Control, REM Sleep and Dopamine

Parkinson's connection, personal information.

Time in Elektrostal , Moscow Oblast, Russia now

• Tokyo 12:30PM
• Beijing 11:30AM
• Kyiv 06:30AM
• Paris 05:30AM
• London 04:30AM
• New York 11:30PM
• Los Angeles 08:30PM

Time zone info for Elektrostal

• The time in Elektrostal is 8 hours ahead of the time in New York when New York is on standard time, and 7 hours ahead of the time in New York when New York is on daylight saving time.
• Elektrostal does not change between summer time and winter time.
• The IANA time zone identifier for Elektrostal is Europe/Moscow.

Time difference from Elektrostal

Sunrise, sunset, day length and solar time for elektrostal.

• Sunrise: 03:42AM
• Sunset: 09:08PM
• Day length: 17h 26m
• Solar noon: 12:25PM
• The current local time in Elektrostal is 25 minutes ahead of apparent solar time.

Elektrostal on the map

• Location: Moscow Oblast, Russia
• Latitude: 55.79. Longitude: 38.46
• Population: 144,000

Best restaurants in Elektrostal

• #1 Tolsty medved - Steakhouses food
• #2 Ermitazh - European and japanese food
• #3 Pechka - European and french food

Find best places to eat in Elektrostal

• Best pubs & bars in Elektrostal
• Best steak restaurants in Elektrostal
• Best bbqs in Elektrostal

The 50 largest cities in Russia

• Yekaterinburg
• Novosibirsk
• Vladivostok

• Tours to Russia
• Practicalities
• Russia in Lists

Rusmania • Deep into Russia

Out of the Centre

Savvino-storozhevsky monastery and museum.

Zvenigorod's most famous sight is the Savvino-Storozhevsky Monastery, which was founded in 1398 by the monk Savva from the Troitse-Sergieva Lavra, at the invitation and with the support of Prince Yury Dmitrievich of Zvenigorod. Savva was later canonised as St Sabbas (Savva) of Storozhev. The monastery late flourished under the reign of Tsar Alexis, who chose the monastery as his family church and often went on pilgrimage there and made lots of donations to it. Most of the monastery’s buildings date from this time. The monastery is heavily fortified with thick walls and six towers, the most impressive of which is the Krasny Tower which also serves as the eastern entrance. The monastery was closed in 1918 and only reopened in 1995. In 1998 Patriarch Alexius II took part in a service to return the relics of St Sabbas to the monastery. Today the monastery has the status of a stauropegic monastery, which is second in status to a lavra. In addition to being a working monastery, it also holds the Zvenigorod Historical, Architectural and Art Museum.

Belfry and Neighbouring Churches

Located near the main entrance is the monastery's belfry which is perhaps the calling card of the monastery due to its uniqueness. It was built in the 1650s and the St Sergius of Radonezh’s Church was opened on the middle tier in the mid-17th century, although it was originally dedicated to the Trinity. The belfry's 35-tonne Great Bladgovestny Bell fell in 1941 and was only restored and returned in 2003. Attached to the belfry is a large refectory and the Transfiguration Church, both of which were built on the orders of Tsar Alexis in the 1650s.  

To the left of the belfry is another, smaller, refectory which is attached to the Trinity Gate-Church, which was also constructed in the 1650s on the orders of Tsar Alexis who made it his own family church. The church is elaborately decorated with colourful trims and underneath the archway is a beautiful 19th century fresco.

Nativity of Virgin Mary Cathedral

The Nativity of Virgin Mary Cathedral is the oldest building in the monastery and among the oldest buildings in the Moscow Region. It was built between 1404 and 1405 during the lifetime of St Sabbas and using the funds of Prince Yury of Zvenigorod. The white-stone cathedral is a standard four-pillar design with a single golden dome. After the death of St Sabbas he was interred in the cathedral and a new altar dedicated to him was added.

Under the reign of Tsar Alexis the cathedral was decorated with frescoes by Stepan Ryazanets, some of which remain today. Tsar Alexis also presented the cathedral with a five-tier iconostasis, the top row of icons have been preserved.

Tsaritsa's Chambers

The Nativity of Virgin Mary Cathedral is located between the Tsaritsa's Chambers of the left and the Palace of Tsar Alexis on the right. The Tsaritsa's Chambers were built in the mid-17th century for the wife of Tsar Alexey - Tsaritsa Maria Ilinichna Miloskavskaya. The design of the building is influenced by the ancient Russian architectural style. Is prettier than the Tsar's chambers opposite, being red in colour with elaborately decorated window frames and entrance.

At present the Tsaritsa's Chambers houses the Zvenigorod Historical, Architectural and Art Museum. Among its displays is an accurate recreation of the interior of a noble lady's chambers including furniture, decorations and a decorated tiled oven, and an exhibition on the history of Zvenigorod and the monastery.

Palace of Tsar Alexis

The Palace of Tsar Alexis was built in the 1650s and is now one of the best surviving examples of non-religious architecture of that era. It was built especially for Tsar Alexis who often visited the monastery on religious pilgrimages. Its most striking feature is its pretty row of nine chimney spouts which resemble towers.

Plan your next trip to Russia

Ready-to-book tours.

Your holiday in Russia starts here. Choose and book your tour to Russia.

REQUEST A CUSTOMISED TRIP

Looking for something unique? Create the trip of your dreams with the help of our experts.

IOWA Research Park

Integrated DNA Technologies Invests in New U.S. Synthetic Biology Manufacturing Facility

CORALVILLE, Iowa (May 28, 2024) –Global genomics solutions provider Integrated DNA Technologies (IDT) today announced the expansion of its synthetic biology operations with the opening of a new 25,000 square-foot-site in Coralville, IA. The two-story building will be dedicated to the manufacturing of IDT synthetic biology products, doubles IDT's synthetic biology footprint, and enables IDT to further enhance its gene synthesis portfolio with differentiated offerings.

"The expansion of our synthetic biology manufacturing operations adds significant capacity for IDT and lays the foundation for the future growth of our synthetic biology product portfolio, says Demaris Mills, President, IDT. "With this increased footprint, we will be introducing new product enhancements, which will include the launch of a rapid gene synthesis offering expected in late Q2. This investment provides IDT with a growth runway for its synthetic biology product portfolio and manufacturing arm to support the rapidly expanding global DNA synthesis market and related drug development activity."

Proximate to IDT's flagship U.S. headquarters, more than half of the 25,000 square-foot facility has been dedicated to synthetic biology lab spaces. Other areas include office and conference rooms, amenities, onsite dedicated support resources, and additional space for future expansion. Notable lab features include enhanced cold storage, facility and flow designed for lean manufacturing, and LED lighting and building automation systems to enable energy efficient building performance. The facility will be operational 24 hours a day, seven days a week.

The investment comes after IDT's recent launch of the new custom vector onboarding tool to equip researchers with an easy-to-use solution that enables them to skip in-house cloning steps and move quickly into functional studies with 100% sequence-verified clonal DNA. The launch was the latest addition to IDT's broad synthetic biology portfolio comprised of gene and gene fragment offerings. As a large-scale provider of synthetic DNA, IDT can make gene fragments between 125 bp to 3 kb, and custom genes from 25 bp to over 5 kb.

The expansion of IDT's synthetic biology manufacturing facility marks the second facility completion for IDT within the last 12 months. In late 2023, IDT announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Iowa, which commemorated its entrance into the therapeutics space.

For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has empowered genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, featuring the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases.

Seeking to fulfill its mission of accelerating the pace of genomics, IDT acquired Archer™ NGS Research Assays in December 2022. When combined with its existing solutions, the expanded portfolio helps realize the shared vision of enabling researchers to rapidly move from the lab to life-changing advances.

IDT's infrastructure supports customers around the globe with its manufacturing headquarters situated in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Boulder, Colorado, USA; Research Triangle Park, North Carolina, USA; Ann Arbor, Michigan, USA; Leuven, Belgium; and Singapore.

IDT is proud to be part of Danaher. Danaher's science and technology leadership puts IDT’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers.

Together with Danaher's other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

For more information about IDT, visit www.idtdna.com  and follow the company on LinkedIn , X , Facebook , YouTube , and Instagram .

RUO24-2887_001

Board of Trustees (BOT)

Mr. Joseph Luper Tsenum

(Founder/Executive Director)

Mr. Imanche Moses Joshua

(Program Manager/Chief Financial Officer)

Dr. Solomon Ngutor Dzever

Mr. Shadrach Nengenen Mbativga

(Member/Graduate Scholarship Coordinator)

Pastor Dr. Ezekiel Hanior

Mr. Agu Viashima

Mr. Isaac Ahangba Akor

Mr. Mfeuter Joseph Tachia

(Counseling/Consultancy Coordinator)

Mrs. Patience Emaikwu

(Administrative Manager)

Mr. Emmanuel Stephen Sunday

(Training Officer)

Engr. Akuha Simon Iorshagher

(Account Manager)

Mr. Ochoche Shaibu

(Scholarship Coordinator)

Mr. Isaac Omiagocho ThankGod

(Research and Technology Coordinator)

Mr. Gabriel Terkuma saAôndo

(Campus and Organizational Visitation Coordinator)

Mr. Obed Kohol Niambe

Dr. Ene Esther Idota

(Content Editorial Coordinator)

Mr. Daniel Terhemen Tuleun

(Undergraduate Scholarship Coordinator)

Departmental / Unit Advisors

Mrs. Juliet Abeyi Icighan

Ms. Felicia Bulus

Ms. Naomi Doosuur Torjir

Mr. David Okoli

Mr. Duna Jilang

Mr. Innocent Peter Acha

Comr. Anngu Orngu

Mrs. Salamatu Lawal

Mrs. Faith Chinonye Eke

Dr. Stephen Aremu

Mrs. Comfort Ehi Onjewu

Mrs. Glory Ade Iorliam

• Community Events

Gino Macchio Foundation’s First Annual Charity Golf Outing is June 4 at Stonebridge Golf Links and Country Club

The Gino Macchio Foundation’s First Annual “I Got You” Golf Outing to support their Put Recovery to Work Program is happening on June 4 at the Stonebridge Golf Links and Country Club in Smithtown.

The inaugural golf outing will honor Smithtown Town Supervisor Ed Wehrheim for his strong advocacy of the Foundation’s Put Recovery to Work mission. "It has been an absolute joy and privilege to work with the Gino Macchio Foundation on Put Recovery to Work. It is the missing link in helping to achieve an individual's path towards success in sobriety, removing the stigma and giving back purpose to one’s life. I’m deeply humbled to be honored during the inaugural golf outing." - Supervisor Ed Wehrheim

The golf outing which begins at the 11:30am check in, includes grab & go breakfast, BBQ lunch on the patio, snacks and refreshments while on the course, and a buffet dinner with open bar. Tickets and event sponsorships can be purchased at https://givebutter.com/gmfgolfday2024 .

The Gino Macchio Foundation’s Put Recovery to Work program is leading the way on Long Island by providing a boost for people in recovery to attain and maintain employment. Research shows that gainful employment instills meaning into the lives of people in active recovery from substance use disorders, resulting in a higher likelihood of desired outcomes. Businesses benefit with employees who work hard to maintain the trust employers have shown them by hiring them. Dollars raised at the Golf Outing will be used to fund the program’s activities.

These are some of the ways the Foundation supports individuals in recovery:

• Provide employees in recovery financial support and tools to remove barriers to employment. Customized scholarship programs can be used to pay for transportation expenses, clothing, housing, work tools, or other items that affect employment status. • Make a financial contribution to the employer towards the salary of hired individuals in the first year of employment. • Partner with recovery community organizations and other groups who provide treatment to those in recovery.

About the Gino Macchio Foundation: The Gino Macchio Foundation, a 501 ( c ) (3) not-for-profit organization, was formed in 2019 after the death of Gino Macchio in a left-turn motorcycle crash. At that point in time Gino was in active recovery and had successfully turned his life around for the better. Gino paid it forward by helping others who had been in his shoes. Inspired by his life motto: “I Got You,” Gino’s family and friends have taken his dream a step further, empowering individuals in recovery by providing financial and tangible resources to remove barriers to gainful employment and encouraging Long Island based businesses to become recovery-friendly workplaces. For more information visit: www.GinoMacchioFoundation.com or call (631) 496-6179.

Event Supported By